美股市场个股详情
DXCM 德康医疗
- 77.990
- -0.110-0.14%
收盘价 11/29 13:00 (美东)
- 77.709
- -0.281-0.36%
盘后 17:02 (美东)
304.63亿总市值47.27市盈率TTM
79.370最高价77.890最低价151.04万股成交量78.400今开78.100昨收1.18亿成交额0.39%换手率59.99市盈率(静)3.91亿总股本142.00052周最高15.39市净率302.18亿流通值62.34052周最低--股息TTM3.87亿流通股164.863历史最高--股息率TTM1.90%振幅0.340历史最低78.352平均价1股每手
关于德康医疗公司
德康医疗公司为糖尿病患者设计并商业化连续血糖监测（CGM）系统。连续血糖监测系统可作为传统血糖仪工艺的替代方案，该公司正在发展其连续血糖监测系统，以提供与胰岛素泵的集成，以实现胰岛素的自动输送。
公司介绍
公司代码DXCM
公司名称德康医疗
上市日期2005/04/14
发行价格12.00
成立日期1999
所属市场纳斯达克
员工数量9600
年结日12-31
公司地址6340 Sequence Drive
城市San Diego
省份加利福尼亚州
国家美国
邮编92121
电话1-858-200-0200
董事高管
-
姓名
- 职务
- 年薪
-
Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 1571.22万
-
Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 652.66万
-
Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 425.49万
-
Michael Brown
- Executive Vice President and Chief Legal Officer
- 434.28万
-
Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
-
Jake Leach
- Executive Vice President and Chief Operating Officer
- 493.80万
-
Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
-
Karen M. Dahut
- Independent Director
- 34.59万
-
Bridgette P. Heller
- Independent Director
- 34.65万
-
Nicholas Augustinos
- Independent Director
- 36.22万
-
Kyle Malady
- Independent Director
- 34.34万
-
Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 34.65万
-
Richard A. Collins
- Independent Director
- 34.59万
-
Mark G. Foletta
- Lead Independent Director
- 39.35万
-
Rimma Driscoll
- Independent Director
- 40.47万
-
Steven R. Altman
- Independent Director
- 34.34万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
